Nurix Therapeutics Inc (NRIX) Ownership

22.05 ↓0.32 (-1.43%)
As of December 31, 1969, 7:00pm EST.

Institutional Ownership

BlackRock Inc is the biggest individual institutional holder of Nurix Therapeutics Inc (NRIX), owning a total of 6.8 million shares. Combined, the top 36 institutional holders of NRIX own 102.69% of the company with a total of 67.7 million shares.

In the latest ownership report on June 30th 2024, the top 36 institutional holders increased their combined ownership of NRIX by 12.6 million shares. 14 institutions bought 14,871,281 total additional shares and increased their ownership by an average of 227.71%. However 6 institutions sold 2,304,067 total shares and decreased their ownership by an average of 16%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Nurix Therapeutics Inc increased by a net total of 12,567,214 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc9.628%48.895%6,820,0152,239,6012024-06-30
Redmile Group, LLC6.245%-1.325%4,423,616-59,4002024-06-30
Deep Track Capital, LP5.635%33.146%3,991,500993,6702024-06-30
Morgan Stanley - Brokerage Accounts5.618%-21.381%3,979,400-1,082,1982024-06-30
Baker Bros Advisors LP5.480%0.000%3,882,12502024-06-30
Vanguard Group Inc5.118%40.271%3,625,0141,040,7142024-06-30
Wellington Management Company LLP4.520%1,273.390%3,201,8652,968,7292024-06-30
T. Rowe Price Associates, Inc.4.002%29.094%2,835,119638,9502024-06-30
State Street Corp3.824%-0.762%2,708,533-20,8032024-06-30
ARK Investment Management LLC3.280%-11.839%2,323,332-312,0062024-06-30
T. Rowe Price Investment Management,Inc.3.091%0.000%2,189,1922,189,1922024-06-30
Soleus Capital Management, L.P.2.902%84.387%2,055,916940,9162024-06-30
Geode Capital Management, LLC1.866%20.121%1,321,734221,3992024-06-30
Driehaus Capital Management LLC1.811%0.000%1,283,1081,283,1082024-06-30
Pictet Asset Manangement SA1.657%61.432%1,173,518446,5772024-06-30
Candriam Luxembourg S.C.A.1.644%30.505%1,164,246272,1362024-06-30
Deutsche Bank AG1.480%-30.078%1,048,394-450,9742024-06-30
Citadel Advisors Llc1.469%1,419.930%1,040,666972,1982024-06-30
Nuveen Asset Management, LLC1.385%134.268%981,167562,3442024-06-30
Affinity Asset Advisors, LLC1.288%12.557%912,000101,7472024-06-30
Wasatch Advisors LP1.332%-30.619%858,067-378,6862024-06-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc9.628%48.895%6,820,0152,239,6012024-06-30
Redmile Group, LLC6.245%-1.325%4,423,616-59,4002024-06-30
Deep Track Capital, LP5.635%33.146%3,991,500993,6702024-06-30
Morgan Stanley - Brokerage Accounts5.618%-21.381%3,979,400-1,082,1982024-06-30
Baker Bros Advisors LP5.480%0.000%3,882,12502024-06-30
Vanguard Group Inc5.118%40.271%3,625,0141,040,7142024-06-30
Wellington Management Company LLP4.520%1,273.390%3,201,8652,968,7292024-06-30
T. Rowe Price Associates, Inc.4.002%29.094%2,835,119638,9502024-06-30
Wasatch Advisors Inc.5.624%-22.860%2,749,745-814,8712023-12-31
State Street Corporation4.237%196.241%2,729,3361,808,0142024-03-31
State Street Corp3.824%-0.762%2,708,533-20,8032024-06-30
ARK Investment Management LLC3.280%-11.839%2,323,332-312,0062024-06-30
T. Rowe Price Investment Management,Inc.3.091%0.000%2,189,1922,189,1922024-06-30
Soleus Capital Management, L.P.2.902%84.387%2,055,916940,9162024-06-30
TRV GP III, LLC4.078%0.000%1,922,54902022-06-30
Geode Capital Management, LLC1.866%20.121%1,321,734221,3992024-06-30
Driehaus Capital Management LLC1.811%0.000%1,283,1081,283,1082024-06-30
Boxer Capital LLC2.505%0.000%1,224,89202023-09-30
Pictet Asset Manangement SA1.657%61.432%1,173,518446,5772024-06-30
Candriam Luxembourg S.C.A.1.644%30.505%1,164,246272,1362024-06-30
Bain Capital Life Sciences Investors, LLC1.758%-37.879%1,132,397-690,4862024-03-31
Deutsche Bank AG1.480%-30.078%1,048,394-450,9742024-06-30
Citadel Advisors Llc1.469%1,419.930%1,040,666972,1982024-06-30
Nuveen Asset Management, LLC1.385%134.268%981,167562,3442024-06-30
Dimensional Fund Advisors, Inc.1.500%-3.359%966,453-33,5912024-03-31
Affinity Asset Advisors, LLC1.288%12.557%912,000101,7472024-06-30
Wasatch Advisors LP1.332%-30.619%858,067-378,6862024-06-30
TCG Crossover Management, LLC1.175%0.000%717,654717,6542023-12-31
Foresite Capital Management IV, LLC1.436%-34.309%677,143-353,6552022-06-30
Millennium Management LLC1.329%39.606%644,411182,8192023-06-30
Charles Schwab Investment Management Inc0.997%3.197%642,19019,8932024-03-31
Dafna Capital Management LLC1.139%0.000%556,69502023-09-30
Bank of America Corp1.118%-7.070%546,450-41,5752023-09-30
Goldman Sachs Group Inc0.765%-12.617%492,666-71,1342024-03-31
Northern Trust Corp0.902%2.849%440,85212,2102023-09-30
FMR Inc0.859%-53.735%416,613-483,8752023-06-30

Mutual Fund Ownership

ARK Genomic Revolution is the biggest individual fund holder of Nurix Therapeutics Inc (NRIX), owning a total of 2.2 million shares. Combined, the top 41 mutual fund holders of NRIX own 50.52% of the company with a total of 32 million shares.

In the latest ownership report on October 31st 2024, the top 41 fund holders increased their combined ownership of NRIX by 15 thousand shares. 1 funds bought 6,176 total additional shares and increased their ownership by an average of 0.29%. However 3 funds sold 20,898 total shares and decreased their ownership by an average of 0.75%.

Overall this is a negative sign as the number of shares owned by the top 20 mutual funds holding Nurix Therapeutics Inc decreased by a net total of -14,722 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Genomic Revolution ETF2.971%0.294%2,104,8306,1762024-10-31
iShares Russell 2000 ETF2.318%-0.225%1,642,282-3,6962024-10-31
SPDR® S&P Biotech ETF1.421%-1.424%1,006,213-14,5322024-10-31
iShares Biotechnology ETF0.631%-0.594%447,133-2,6702024-10-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Genomic Revolution3.108%-4.144%2,201,225-95,1712024-09-30
Vanguard Total Stock Mkt Idx Inv3.005%10.172%2,128,355196,5002024-09-30
ARK Genomic Revolution ETF2.971%0.294%2,104,8306,1762024-10-31
iShares Russell 2000 ETF2.318%-0.225%1,642,282-3,6962024-10-31
Vanguard Instl Ttl Stck Mkt Idx Tr3.240%29.436%1,571,546357,4002023-03-31
T. Rowe Price New Horizons2.052%-0.314%1,453,367-4,5802024-09-30
US Small-Cap Growth II Equity Comp2.052%-0.354%1,453,367-5,1682024-09-30
Eventide Healthcare & Life Sciences I2.448%-38.289%1,154,000-716,0002022-06-30
SPDR® S&P Biotech ETF1.421%-1.424%1,006,213-14,5322024-10-31
Pictet-Biotech P USD1.397%45.378%989,284308,7932024-07-31
Vanguard Institutional Extnd Mkt Idx Tr1.283%6.734%909,12157,3542024-09-30
Wasatch Small Cap Growth Investor1.852%-2.514%898,101-23,1602023-09-30
Wasatch Small Cap Value1.430%29.273%702,910159,1682023-12-31
Candriam Global Equities Oncology0.882%-14.067%624,817-102,2792024-09-30
Belfius Equities Cure C Cap0.882%-18.548%624,817-142,2792024-09-30
Pictet-Global Megatrend Sel I USD0.875%37.672%620,088169,6772024-07-31
Fidelity Small Cap Index0.875%-2.493%620,073-15,8512024-08-31
BlackRock Health Sciences Opps Inv A0.875%0.000%619,55702024-09-30
Vanguard Extended Market Index Investor1.278%-0.029%616,077-1812023-08-31
T. Rowe Price Small-Cap Stock0.853%0.000%603,858603,8582024-09-30
T. Rowe Price US Small-Cap Core Equity0.853%0.000%603,858603,8582024-09-30
UBS: US Equity Small Cap Growth1.205%0.000%589,17602023-09-30
Wasatch Ultra Growth0.818%-37.048%548,977-323,0752024-06-30
Xtrackers MSCI World Swap ETF 1C0.759%0.000%537,68002024-09-30
T. Rowe Price Small-Cap Value0.757%-10.116%536,000-60,3232024-09-30
Nuveen Quant Small Cap Equity R60.812%0.000%523,10002024-07-31
TIAA-CREF Quant Small-Cap Equity Instl1.026%20.000%501,61083,6002024-01-31
T. Rowe Price Integrated US SmCapGrEq0.696%88.632%492,854231,5762024-09-30
T. Rowe Price Integrated US Sm Gr Eq0.696%22.944%492,85491,9762024-09-30
Xtrackers S&P Global Infra Swap ETF 1C0.751%0.000%483,68802023-12-31
Fidelity® Small Cap Index0.940%1.146%456,1115,1682023-10-31
iShares Biotechnology ETF0.631%-0.594%447,133-2,6702024-10-31
Candriam Eqs L Biotech C USD Cap0.652%0.000%437,10702024-08-31
iShares Russell 2000 Value ETF0.706%-0.133%431,115-5722024-05-30
Pictet Biotech0.601%0.000%403,257403,2572024-03-31
BlackRock Health Sciences Term Trust0.601%0.000%387,01602024-05-31
Fidelity® Select Biotechnology0.756%0.000%366,64602023-08-31
Wasatch Micro Cap0.717%27.338%352,48275,6732023-12-31
Nuveen Quant Small Cap Equity Instl0.501%-38.987%306,050-195,5602024-02-29
State St Russell Sm/Mid Cp® Indx NL Cl C0.482%0.000%294,51302024-04-30
Schwab Small-Cap Equity0.467%6.284%284,88916,8432024-03-31

Discussions

Please log in or register to share your thoughts.